Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 816 results for "drl"

US FDA discovers lapses at DRL's Srikakulam plant

US health regulator Food and Drug Administration (FDA) has procedural deviations at Dr Reddy's Laboratories manufacturing plant at Srikakulam Hyderabad: US health regulator Food and Drug Administration (FDA) has procedural deviations at Dr ... Deccan Chronicle, 1 day ago
Srikakulam plant gets Form 483 for lapses: DRL Financial Chronicle, 1 day ago

12 images for drl

Motor Trend India, 3 days ago
Rush Lane, 2 weeks ago, 2 weeks ago, 2 weeks ago
Greentech Lead, 3 weeks ago
Citybizlist, 3 weeks ago
Style Bistro, 3 weeks ago
American Banking News, 1 month ago
WHIO TV, 1 month ago
India TV, 1 month ago

DRL Visakhapatnam Plant Gets FDA Fiat on Suspected Lapses

HYDERABAD: Dr Reddy's Laboratories Ltd (DRL) came under the US health regulator Food and Drug Administration (FDA) scanner for procedural deviations at one of its manufacturing plants in Visakhapatnam. It may be noted that the FDA had conducted an ...
 New Indian Express1 day ago Government Eyes $340 Billion Exports This Fiscal  INooz1 day ago Lubiprostone Patent Row Lands DRL in Court  New Indian Express3 days ago

DRL receives 483 observations for Unit 6 of Vizag plant

The Vizag plant, which manufactures active pharmaceutical ingredient (API) and bulk drugs, was visited by the US Food and Drug Administration last week.
 Money Control1 day ago

DRL launches Docetaxel

Dr Reddy's Laboratories has launched Docetaxel injection USP 20 mg/mL and 80 mg/4 mL, a generic version of Taxotere (docetaxel injection) in the US market. Dr Reddy's Abbreviated New Drug Application (ANDA) is approved by the United States Food & ...
 The Echo Of India3 days ago DRL launches Docetaxel injection in US  Press Trust of India4 days ago Dr Reddy Laboratories : LAUNCHES OTC TABLETS IN US  4 Traders6 days ago DR REDDY LABORATORIES : Bt500 rankings: india's most valuable top-500 companies - dr reddy's laboratories limited  4 Traders1 week ago

RANBAXY LABORATORIES : Loses Bid To Block Endo And DRL From Launching Generic Nexium And Valcyte

Following, and in response to, the revocation of Ranbaxy's tentative approvals for Ranbaxy's ANDAs for esomeprazole magnesium delayed-release capsules and valganciclovir hydrochloride tablets, Ranbaxy has filed a complaint against the U.S. Food and ...
 4 Traders6 days ago Here's why Sun, Lupin, DRL are still best pharma bets  Money Control1 week ago Ranbaxy, Sun Pharma fall 4-5%; analysts say DRL to benefit  Money Control3 weeks ago

US FDA Conducts Inspection at DRL's Vizag facility

Looks like you are looking for a page that doesn't exist or has been moved. Please check the url to see if there are any mistakes or use the search box below to find the content you are looking for. If you still have difficulty finding what ...
 New Indian Express1 week ago

Buy Dr Reddys Labs; target of Rs 3750: Angel Broking

Angel Broking`s research report on Dr Reddys Labs For 2QFY2015, Dr Reddy's Laboratories (DRL) posted net sales of Rs3,587.9cr (V/s an expected Rs3,900cr), a yoy growth of 6.9% yoy. The growth was subdued as the US geography which is the company's ...
 Moneycontrol.com1 week ago Accumulate Dr Reddys Labs; target of Rs 3485: KRChoksey  Moneycontrol.com3 weeks ago Dr Reddy's Laboratories 2QFY2015 performance highlights and results update  Stock Markets Review3 weeks ago

Sensex, Nifty maintain uptrend; OBC, DRL fall post Q2 nos

Hindalco, Tata Motors, MM, Tata Steel and Infosys are top gainers in the Sensex. Among the losers are, BHEL, GAIL and Sun Pharma.
 Money Control4 weeks ago Sensex, Nifty weak; BHEL, Infosys, DRL, Hero shine  Money Control1 month ago Sensex rangebound; Infosys, Sun Pharma, TCS and DRL top losers  Economic Times1 month ago
Business Standard


The probe launched by the US legislature against Dr Reddy's Laboratories (DRL) and Sun Pharmaceuticals Industries Limited (Sun) of India over a steep increase in their drug prices in the US market is set to intensify. A panel formed ...
 Pharmacy Choice1 week ago US Congress steps up pressure for action on Sun Pharma, DRL  Business Standard India1 month ago DRL, Sun Pharma among 14 companies facing price probe in US  Times of India1 month ago DRL, Sun Pharma among 14 cos facing price probe in US  Times of India1 month ago

Lack of US launches eats into DRL's Sept quarter profits

Pharma major Dr Reddy's Laboratories (DRL) has reported a 16.8% decline in its consolidated net profit to R574.10 crore in the September quarter compared to R690.25 crore a year earlier. The fall in profit was due to lack of new product launches in ...
 Financial Express4 weeks ago DR REDDY LABORATORIES : Lack of us launches eats into drl's sept quarter profits  4 Traders3 weeks ago DRL donates Rs 2 crs to Hudhud cyclone relief fund  Express Pharma1 month ago DRL sues ex-associate over non-compete deal  The Financial Chronicle1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less